Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 271,631
  • Shares Outstanding, K 68,421
  • Annual Sales, $ 0 K
  • Annual Income, $ -118,460 K
  • EBIT $ -168 M
  • EBITDA $ -168 M
  • 60-Month Beta 2.24
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.39

Options Overview Details

View History
  • Implied Volatility 148.65% ( +28.96%)
  • Historical Volatility 63.26%
  • IV Percentile 98%
  • IV Rank 74.46%
  • IV High 188.84% on 12/17/24
  • IV Low 31.44% on 08/22/24
  • Put/Call Vol Ratio 0.70
  • Today's Volume 508
  • Volume Avg (30-Day) 511
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 41,929
  • Open Int (30-Day) 40,367

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.63
  • Number of Estimates 4
  • High Estimate -0.57
  • Low Estimate -0.71
  • Prior Year -0.53
  • Growth Rate Est. (year over year) -18.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.86 +2.85%
on 12/18/24
4.91 -19.14%
on 12/09/24
-0.69 (-14.81%)
since 11/20/24
3-Month
3.86 +2.85%
on 12/18/24
7.30 -45.62%
on 09/23/24
-3.28 (-45.24%)
since 09/20/24
52-Week
3.86 +2.85%
on 12/18/24
12.75 -68.86%
on 02/28/24
-3.56 (-47.28%)
since 12/20/23

Most Recent Stories

More News
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?

Don't jump in without doing some research first.

CMPS : 3.97 (+1.28%)
AACG : 0.8400 (+1.33%)
MNMD : 7.16 (+2.07%)
CYBN : 9.61 (+3.11%)
Vaccine Stocks Slide, Psychedelic Stocks Surge After RFK Jr. HHS Nomination

Markets sent a clear message Friday following President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services (HHS). Vaccine stocks took a nosedive,...

CMPS : 3.97 (+1.28%)
PSIL : 10.62 (+1.15%)
ATAI : 1.1900 (unch)
AZN : 65.35 (+1.41%)
BVNRY : 8.9600 (+1.36%)
NVAX : 8.70 (+0.23%)
MRNA : 39.39 (-0.43%)
CYBN : 9.61 (+3.11%)
GSK : 33.60 (+0.51%)
PFE : 26.36 (+2.29%)
BNTX : 113.08 (+1.56%)
SNY : 47.71 (+0.44%)
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript

CMPS earnings call for the period ending September 30, 2024.

CMPS : 3.97 (+1.28%)
Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript

CMPS earnings call for the period ending June 30, 2024.

CMPS : 3.97 (+1.28%)
1 Biotech Stock Under $10 That Could Surge 420%

Down 84% from all-time highs, Compass Pathways is a beaten-down biotech stock that trades at a massive discount to consensus price target estimates in 2024.

CMPS : 3.97 (+1.28%)
RY : 120.72 (+0.84%)
Should You Buy the Dip on Compass Pathways Stock?

Nothing is going wrong, but one of its peers just hit a serious snag.

CMPS : 3.97 (+1.28%)
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.

Regulators were not impressed by one company's petition for approval.

CMPS : 3.97 (+1.28%)
These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring

Psychedelic medicines are rapidly gaining legitimacy on several fronts.

CMPS : 3.97 (+1.28%)
Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

CMPS earnings call for the period ending March 31, 2024.

CMPS : 3.97 (+1.28%)
The Next Great Biotech Boom Has Arrived

EQNX::TICKER_START (NYSE:JNJ),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:ATAI),(NYSE:ABBV) EQNX::TICKER_END

JNJ : 144.47 (+0.62%)
CMPS : 3.97 (+1.28%)
MNMD : 7.16 (+2.07%)
ATAI : 1.1900 (unch)
ABBV : 175.58 (+2.37%)

Business Summary

COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK.

See More

Key Turning Points

3rd Resistance Point 4.45
2nd Resistance Point 4.32
1st Resistance Point 4.15
Last Price 3.97
1st Support Level 3.85
2nd Support Level 3.72
3rd Support Level 3.55

See More

52-Week High 12.75
Fibonacci 61.8% 9.35
Fibonacci 50% 8.31
Fibonacci 38.2% 7.26
Last Price 3.97
52-Week Low 3.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar